Infections associated with avian pathogenic Escherichia coli (APEC) cause severe economic losses to the poultry industry. The study presented herein investigated the in vivo performance of a single phage with prolonged in vivo and in vitro survivability alone or in combination with 3 other selected phages in treating colibacillosis in quails. Japanese quails (N = 360) were randomly assigned to 6 treatment groups with 4 replicate pens. Birds from the control groups (groups I, II, and III) were treated with 200 μL sterile PBS (pH 7.4), 200 μL of the selected phage (10 10 pfu; TM3) or a cocktail of 4 phages (TM3 plus TM1, TM2, and TM4), respectively. Groups IV, V, and VI were challenged with 200 μL E. coli (10 8 cfu; O78:K80 and O2:K1) and treated with i.m. injection of 200 μL sterile PBS, phage TM3, or cocktail of 4 phages, respectively. Based on the results of the present study, the total mortality rate decreased from 46.6% in the untreated E. coli-challenged group to 26.5% and 13.6% in the E. coli-challenged group treated with single phage or phage cocktail, respectively. The body weights of birds treated with the phage cocktail were higher than the body weights of untreated birds on days 7, 14, and 21 post-challenge (P < 0.05). In addition, total viable cell counts of E. coli in the lungs of birds treated with the phage cocktail were lower than those of birds treated with phage TM3 on days 3 and 10 post-challenge (P < 0.05). Moreover, the incidence and severity of lesions in lungs, heart, and liver were found to be significantly less in the E. coli-challenged group treated with the phage cocktail. In conclusion, this study indicates that a phage cocktail may be more efficient in treating colibacillosis than a single phage possibly due to a synergistic effect between the individual phages.
INTRODUCTION
Colibacillosis induced by APEC is a major infectious disease affecting global poultry production (Ghunaim et al., 2014; Lagzian et al., 2016) . The most frequent form of avian colibacillosis is a systemic infection characterized by various symptoms, including multiple organ lesions (e.g., air sacculitis), peritonitis, pericarditis, salpingitis, synovitis, osteomyelitis, or yolk sac infection (Wang et al., 2015) . Among the 171 serogroups of APEC strains, only a limited number of APEC serogroups, such as O1, O2, and O78, are regularly associated with infection in the field (Oh et al., 2011) . However, in the case of predisposing conditions such as immunosuppressive illnesses, Escherichia coli strains in the intestinal environment of healthy birds carrying virulence factors associated with APEC may also cause C 2018 Poultry Science Association Inc.disease (Collingwood et al., 2014) . In addition, the close genetic relationship between APEC and other extraintestinal pathogenic E. coli (ExPEC) associated with human health issues have led to suggestions that APEC may represent a zoonotic risk (Tivendale et al., 2010; Mora et al., 2013) .
Bacteriophages are viruses, which attack and infect bacteria (Hyman and Abedon, 2009) . Bacteriophages are usually very specific in their tropism, affecting only the targeted bacterial species with no disruption in the normal flora (Hong et al., 2016) . Phage therapy, or the therapeutic use of lytic bacteriophages to treat pathogenic bacterial infections, has gained a great deal of interest especially given the global threat of multidrug resistant bacteria (Nobrega et al., 2015) . Hence, numerous studies describing the efficacy of phages in treating bacterial infections in animals have been published in the past decade (Oliveira et al., 2010; Li et al., 2012; Fischer et al., 2013; Huff et al., 2013; Tsonos et al., 2014a; Ahmadi et al., 2016) . In addition, beneficial effects of bacteriophages as an alternative to antibiotic 653 growth promoters have been reported on the performance of poultry and pigs (Yan et al., 2012; Kim et al., 2015; Ahmadi et al., 2016) . However, resistance to phage or phage neutralization may reduce the effectiveness of phage applications against pathogenic bacteria (Kim et al., 2015) . As such, combinations of unrelated different phages with complementary features are often used in efforts to mitigate issues of phage resistance development (Hall et al., 2012) .
Phage efficacy may also be limited by the host immune system, especially when treatments are administered by injection (Huff et al., 2010) . Ly-Chatain (2014) found that clearance of phages by the reticuloendothelial system or phage-neutralizing antibodies could diminish the efficacy of phage therapy.
Bacteriophages are the most abundant and potentially most diverse biological entities on Earth (Sarhan and Azzazy, 2015) . Owing to this fact, it is often relatively simple to isolate phages from a variety of sources (Gorski et al., 2012) . In our study, we hypothesized that phages that regularly circulate in poultry populations may be protected from inactivation or clearance by the immune system, so it can contribute to improving the clinical outcomes. Therefore, the main aim of our study was to evaluate the efficacy of a single phage with prolonged circulation time in the chicken bloodstream (TM3) alone or combined with 3 other phages with slightly shorter circulation times (TM1, TM2, and TM4) for the use in the biological control of colibacillosis in Japanese quails.
MATERIALS AND METHODS

Bacterial Strains
Three strains of APEC (serogroups: O1:K1, O2:K1, and O78:K80) and 2 human extraintestinal pathogenic E. coli strains (ExPEC; O126:K71 and O86:K61) were supplied by the Razi Vaccine and Serum Research Institute (Karaj, Iran).
Bacteriophage Isolation and Purification
Poultry wastewater were obtained from a poultry slaughterhouse and suspended 1:10 (w/v) in salt of magnesium buffer (SM; 50 mM Tris-HCl [pH 7.5], 0.10 M NaCl, 8 mM MgSO 4 ·7H 2 O, 0.01% gelatin [Sigma, Germany] ) and centrifuged at 14,000× g for 20 min at 4
• C. The resulting supernatant was filtered through a 0.22-μm membrane filter (Jet Biofil, China). Two hundred microliter of each filtered sample and 75 μL of fresh log-phase E. coli O78:K80 (OD 600 = 0.6) were mixed with 4 mL of soft LuriaBertani (LB) agar (LB broth with 0.7% agar), applied to bottom layers of LB plates containing 1.5% agar (Serva, Germany), and incubated at 37
• C for 24 h. Resulting plaques were purified 8 times to ensure that each isolate represented a single clone. The sensitivity of 5 E. coli serotypes to isolated phages was determined by spot plating phage lysates on bacterial lawns (Mirzaei and Nilsson, 2015) . From a library of 50 phages, 4 phages with the broadest host range (3 strains of APEC [O1:K1, O2:K1, and O78:K80]  and 2 strains of ExPEC [O126:K71 and O86:K61])  were selected for further experiments: vB EcoS TM1  (TM1), vB EcoS TM2 (TM2), vB EcoS TM3 (TM3) , and vB EcoS TM4 (TM4).
Bacteriophage Amplification
Bacteriophages were amplified by applying 50 μL (∼10 5 pfu) to soft agar plates as described above. The plates were incubated for 24 h, flooded with 300 μL of chloroform, and further incubated at 4
• C for 1 h. PBS (4 mL; 0.14 M NaCl, 0.0027 M KCl, 0.01 M Na 2 HPO 4 , 0.0018 M KH 2 PO 4 ; pH 7.4) was added to plate, removed from the plates, and centrifuged at 13,000× g for 15 min. The supernatant was sterilized using 0.22-μm syringe filters. Bacteriophage titers were measured by plaque assay (Supplementary Figure S1 ). This method consistently produced bacteriophage preparations containing 10 11 pfu/mL (Merabishvili et al., 2009 ).
Transmission Electron Microscopy
The 4 phages were characterized by transmission electron microscopy (TEM) at the Thin Film Laboratories at the University of Tehran (Tehran, Iran) based on basic morphology including size, tail structure, and head structure (by the mean of at least 10 measurements). The phage samples were carried on a mesh copper grid with carbon coated formvar film, fixed for 2 min with 2.5% glutaraldehyde, and stained with 2% uranyl acetate. The grid was air-dried for 60 min and the samples were observed with a CM-100 TEM at 100 kV.
Analysis of Bacteriophage Nucleic Acid
Extraction of phage nucleic acid was conducted according to the method of Ahmadi et al. (2016) . A 6-10-μL volume of DNA was digested with a number of restriction enzymes (HindIII, BamHI, EcoRI, and AluI; Serva, Germany) by standard procedures (Sambrook et al., 1989) . Products of digested phage nucleic acid were electrophoresed in 1% agarose gel in TAE buffer (40 mM Tris-acetate, 1 mM EDTA), stained with ethidium bromide (Serva, Germany), and visualized by transillumination with UV light. Genome sizes were estimated using GeneTools from Syngene 4.3.7.0 (Synoptics Ltd. USA).
Experimental Design
One-day-old Japanese quails were obtained from the Tarbiat Modares University's hatchery. The experiments were carried out in a biosecure facility. All the 
Study 1
In order to select a phage with prolonged viability in bloodstream and serum, 25 1-day-old Japanese quails were randomly divided into 5 groups. Birds in each group were injected intravenously with 200 μL (10 10 pfu) of one of 4 phages (TM1, TM2, TM3, and TM4). Control birds (naive birds) were injected with 200 μL of sterile PBS. Blood was collected into heparinized tubes and serum was separated from the blood by centrifugation at 3000× g for 10 min.
In vivo Blood Clearance of Phages Assessment of phage circulation time in the bloodstream was done according to the procedure of Kim et al. (2008) . After phage injection, 200 μL of blood was collected by the wing vein and used to identify circulating phages over time (Figure 3 ). The pfu concentration at time 0 was obtained using blood taken immediately after phage injection. Phage titers in the blood were detected by routine test dilutions on the surface of prepared host bacterial lawns. Five samples per group (N = 5) were tested, and the assay was repeated 3 times. After incubation, the plaques were counted and the titers were calculated.
Phages Neutralization in Serum In vitro phage neutralization was determined by Kim et al. (2008) 's procedure. Briefly, serum samples (100 μL) were obtained from naive birds, diluted with PBS (1:1), and placed into each well of a 96-well cell culture plate containing 100 μL of each phage (10 10 pfu). The plate was incubated at 37
• C and neutralization of phages were assessed by measuring phage concentration at specified time intervals up to 4 h.
Study 2
Japanese quails (N = 360) were randomly assigned to 6 treatment groups with 4 replicate pens. Birds from the control groups (groups I, II, and III) received 200 μL sterile PBS (pH 7.4), 10 10 pfu of the selected phage (TM3) or a cocktail of 4 phages (TM3 plus TM1, TM2, and TM4), respectively. Groups IV, V, and VI were challenged with 10 8 cfu in 200 μL of E. coli (O78:K80 and O2:K1) and treated with PBS, i.m. injection of 10 10 pfu in 200 μL of phage TM3, or i.m. injections of 4 phages at 8 h post-challenge (based on initial test), respectively. The scheme of the study is described in Table 1 .
Colibacillosis was induced by injecting 200 μL of E. coli O78:K80 and O2:K1 into the thoracic air sac when the birds were 15 d of age. The phages used in the cocktails for this study were propagated individually and mixed prior to use. On days 2, 3, 5 and 10 postchallenge, 8 birds from each treatment group were euthanized by cervical dislocation and examined for incidence and severity of gross lesions, organ weights, and quantitative and qualitative isolation of E. coli from organs. Four birds were tested on day 0 post-challenge. Similar examinations were performed on birds suffering mortality during the experimental period.
Efficacy Parameters The efficacy of the treatments was evaluated based on body weight (BW, measured weekly), mortality rate, incidence and severity of the colibacillosis lesions, and concentrations of E. coli in lungs.
After macroscopic examinations of the presence of tissue lesions or fibrinous exudates on the airsacs, heart, and liver, the inner parts of the heart, liver, and spleen were aseptically swabbed onto the MacConkey agar (Merck, Germany). The lungs, liver, heart, and spleen were excised and weighed. The weights of the organs were reported as the percentage relative to BW.
The lungs of birds were weighed and homogenized. Homogenates were serially diluted (10-fold) in phosphate-buffered saline before plating on MacConkey agar (Merck, Germany) and incubating overnight at 37
• C. Pink colonies were considered as presumptive E. coli colonies and enumerated to determine the concentration of E. coli (cfu/g) in the lungs. Concentrations of E. coli in lung samples were compared across treatments to gauge the severity of colonization (Lau et al., 2010) .
The severity of the lesions in various organs was evaluated and scored as follows-air sacs: (0) normal; (1) no lesions; (2) slight lesions (mild cloudiness of air sacs with mild fibrinous exudate); (3) thickened air sac membranes; (4) meaty appearance of air sacs; heart and pericardium: (0) normal; (1) turbid with excessive or cloudy fluid in the pericardial; (2) acute pericarditis; liver: (0) normal; (1) slight amounts of fibrinous; (2) marked perihepatitis. 
Statistical Analysis
The data were analyzed using the generalized linear model (GLM) of SAS with subsequent Duncan's multiple range test (SAS Institute, Cary, NC, USA). Fisher's exact tests were performed to determine significant differences between the treated and untreated E. coli-challenged groups for qualitative analysis of E. coli from different organs and the presence of gross lesions. A chi-squared test was used to analyze he effect of phage therapy on the mortality of birds. Differences were considered statistically significant at P < 0.05.
RESULTS
Bacteriophages Characterized by TEM
TEM imagery (Figure 1) showed that all isolated phage strains had flexible, non-contractile tails, and belonged to the family of Siphoviridae in the order of Caudovirales (Ackermann, 2003) 
Analysis of Bacteriophage Nucleic Acid
The genome of each phage was digested (by restriction enzymes) and analyzed to ensure genetic diversity of the 4 phages (Figure 2 ). Based on the sizes of fragments generated by digestion with EcoRI and BamHI, the estimated sizes of the genome of phages appeared to be between 27 and 46 kb. Phage TM1 had the biggest genome size (45.8 kb), phage TM3 had the smallest genome size (27.1 kb), and phages TM2 and TM4 had genomes with the sizes of 31.4-41.7 kb (Supplementary Table S1 ).
Phage Circulation Time in Blood
Differences in in vivo phage clearance/inactivation between the 4 isolated phages were measured by analyzing circulation time in the bloodstream after injecting 15-day-old quails ( Figure 3A ). Phages TM4 and TM2 were completely inactivated 12 and 18 h after injection, respectively. Phage TM2 was recovered from 11% to 29% of 10 10 pfu after 18 and 24 h incubation. However, the highest phage circulation time in the bloodstream was found in phage TM3 in which the proportion of recovered TM3 was 71% after 24 h.
Phage Neutralization in Serum
In addition to the in vivo animal tests, the potential of the naive 15-day-old quails' sera to neutralize phages in vitro were tested. After 4 h of incubation, 77.33%, 76.67%, 96.32%, and 71.35% of phages TM1, TM2, TM3, and TM4 remained infective, respectively (Figure 3B) . Recovery was significantly reduced for phages TM1, TM2, TM4 but not for TM3.
BW and Mortality
Birds unchallenged with E. coli and given the phage cocktail (group III) had the highest BW at the end of the experiment (Table 2) . On days 7 and 14 post-challenge, the lowest BW was observed in untreated, E. coli-challenged birds (group IV; 163.25 2 Groups I, II, and III served as controls, in which the birds were inoculated with sterile PBS, single phage (TM3), or cocktail of phages (TM3 plus TM1, TM2, and TM4) respectively; group IV was challenged with E. coli (O78:K80 and O2:K1) without subsequent phage treatment; group V was challenged with E. coli (O78: K80 and O2:K1) and treated with phage TM3; group VI was challenged with E. coli (O78:K80 and O2:K1) and treated with the cocktail of phages. and 184.14 g, respectively) and E. coli-challenged birds treated with phage TM3 alone (group V; 164.60 and 197.09 g, respectively; P < 0.05). BWs of E. coli-challenged birds treated with the cocktail of the 4 phages (group VI) were significantly lower than the BW of unchallenged groups (I, II, and III), but higher than groups IV and V throughout the experimental period (P < 0.05). The positive effect of single phage treatment on the BW of birds was observed only on day 21 where BW of birds treated with the single phage was significantly higher in untreated, E. colichallenged birds (group IV; 255.52 vs 215.29 g). Phage therapy significantly reduced the mortality of the birds compared to untreated, E. coli-challenged birds (Table 2 ; P < 0.05).
At the end of the experimental period, the total mortality rate of birds challenged with E. coli (group IV) was 46.6%, whereas the mortality rate of birds exposed to the E. coli challenge and either single phage or phage cocktail was 26.5% and 13.3%, respectively (Table 2 ; P < 0.05). No mortality was seen in the control groups (groups I, II, and III) during the course of the experiment.
Organ Weight
The effect of the treatments on relative organ weight is presented in Table 3 . Enlargement of hearts, lungs, and livers of birds in the untreated E. coli challenged group (group IV) was observed throughout the experimental period beginning from day 2 post-challenge (P < 0.05). In addition, significantly enlarged spleens of these birds were observed on days 3, 5, and 10 post-challenge (P < 0.05). In the E. coli-challenged group treated with phage TM3 (group V), the enlarged organs were detected from days 2-10 post-challenge while, enlargement of organs of birds in the E. colichallenged group treated with phage cocktail (group VI) was observed only on days 2-5 post-challenge (P < 0.05). In addition, the relative liver weight of the phage cocktail treated birds (3.91% and 3.73%, respectively) were significantly lower than those treated with phage TM3 on days 3 and 5 post-challenge (4.33% and 4.23%, respectively; P < 0.05). The largest sizes of the lungs, heart, liver, and spleen were observed in E. coli-challenged groups (groups IV, V, and VI) throughout the experimental period (P < 0.05). Table 3 . Effect of single phage and phage cocktail treatment on relative weights of the lungs, heart, liver, and spleen. 2 Groups I, II, and III served as controls, in which the birds were inoculated with sterile PBS, single phage (TM3), or cocktail of phages (TM3 plus TM1, TM2, and TM4) respectively; group IV was challenged with E. coli (O78:K80 and O2:K1) without treatment; group V was challenged with E. coli (O78:K80 and O2:K1) and treated with the phage TM3; group VI was challenged with E. coli (O78:K80 and O2:K1) and treated with the cocktail of phages.
Quantitative Analysis of E. coli from Lungs
Administration of the cocktail and the single phage (TM3) significantly reduced the number of E. coli by approximately 1.5 log10 cfu/g in unchallenged groups (groups II and III; Table 4) compared to the control group (group I) on days 2, 3, and 5 post-injection. In the untreated, E. coli-challenged group (group IV), the number of E. coli was increased by 4 log10 cfu/g (from 3.96 to 8.21 log10 cfu/g) on days 2 and 3 post-challenge and then decreased gradually to 6.53 log10 cfu/g on day 10, but remained significantly higher than groups V and VI (P < 0.05). The E. coli number in the E. coli-challenged groups treated with phage TM3 or phage cocktail (groups V and VI) was increased by only approximately 2.3 log10 cfu/g (from 3.89 to 6.18 and 3.44 to 5.83 log10 cfu/g, respectively) on day 2 post-challenge, respectively, which was significantly different from E. coli number in unchallenged groups (groups II and III; P < 0.05). Moreover, in the E. colichallenged group treated with phage cocktail (group VI), the number of E. coli was decreased gradually to 4.15 log10 cfu/g on day 10 post-challenge, which was not significantly different from E. coli population in control groups. Birds in the E. coli-challenged group treated with phage TM3 had significantly higher number of E. coli in their lung samples compared to the E. coli number found in birds in the challenged and phage cocktail-treated group and birds in the control group (P < 0.05). However, the highest number of E. coli was observed in the untreated, E. colichallenged group throughout the experimental period (P < 0.05). The detection limit of E. coli recovery was >1 log10 cfu/g.
Isolation of E. coli from Different Organs and Gross Lesions Score
The presence of E. coli in the heart, liver, and spleen were assessed to determine E. coli dissemination in internal organs (Table 5 ). E. coli was recovered from the organs of untreated, E. coli-challenged birds (group IV) on days 2, 3, 5 and 10 post-challenge, but it was not recovered from the organs of phage cocktail-treated birds on day 5 (group VI) and single phage-treated birds on day 10 post-challenge (group V). E. coli in the liver, heart, and spleen of birds in group VI 2 Groups I, II and III served as controls, in which the birds were inoculated with sterile PBS, single phage (TM3) or cocktail of phage (TM3 plus TM1, TM2 and TM4), respectively; group IV was challenged with E. coli (O78:K80 and O2:K1) without treatment; group V was challenged with E. coli (O78:K80 and O2:K1) and treated with the phage TM3; group VI was challenged with E. coli (O78:K80 and O2:K1) and treated with the cocktail of phage. Table 5 . Effect of single and phage cocktail therapy on the frequency and mean severity of lesions (airsacculitis, pericarditis, and perihepatitis) and presence of E. coli on the heart, liver, and spleen. Groups I, II, and III served as controls, in which the birds were inoculated with sterile PBS, single phage (TM3), or cocktail of phage (TM3 plus TM1, TM2, and TM4) respectively; group IV was challenged with E.coli (O78:K80 and O2:K1) without treatment; group V was challenged with E. coli and treated with the phage TM3; group VI was challenged with E. coli (and treated with the cocktail of phage).
2 Number of samples positive with signs vs. number of birds investigated are displayed; comparison between groups III and IV was performed using Fisher's exact test.
* P < 0.05. 3 AS = airsacs; H = heart; L = liver; S = spleen 4 Combined lesion scoring values for severity of aerosacculitis, pericarditis and perihepatitis ± SEM. Lesion score: Air sac, (0) normal; (1) no lesions; (2) slight lesions (mild cloudiness of air sacs with mild fibrinous exudate); (3) thickened air sac membranes; (4) meaty appearance of air sacs. Heart and pericardium: (0) normal; (1) turbid with excessive or cloudy fluid in the pericardial; (2) acute pericarditis. Liver: (0) normal; (1) slight amounts of fibrinous; (2) marked perihepatits.
were isolated only from 2/8 of heart, 3/8 of liver, and 1/8 of spleen samples of these birds on day 2 post-challenge, while in group V, it was still isolated on day 5 post-challenge. The incidence of pericarditis and perihepatits, as well as the severity of the lesion, was the highest in untreated, E. coli-challenged birds throughout the experimental period (group IV; P < 0.05). In group VI, perihepatitis occurred only on days 2-3 post-challenge in 3/8 and 1/8 of the birds, respectively, while in group V, perihepatitis could still be detected in these birds on day 5 (3/8 of the birds). The number of birds with pericarditis and the severity of lesions in group V (Table 5; Figure 4 ) were significantly higher than in group VI throughout the experimental period. Moreover, in all challenged groups, the severity of lesion was decreased gradually from day 2 to day 10 post-challenge.
DISCUSSION
In this study, we compared the efficacy of a single phage with the highest recovery rate from the bloodstream and broad host range (TM3), and a combination of 4 virulent phages (TM3 plus TM1, TM2, and TM4) in controlling APEC-associated colibacillosis in Japanese quails. The results indicated that treatment with phage TM3 alone was not as effective as treatment with a poly-phage combination in controlling the bacterial infection. The increased efficacy of the polyphage treatment may be due to the synergistic effect of the phages in the cocktail. However, the single animal trial performed in the present work must be repeated and synergy must be studied in details. Our study also suggested that both injection of the single phage and the poly-phage combination in E. coli-challenged birds led to higher growth rates and lower mortality rates compared to E. coli-challenged birds receiving no phage treatment. Our results support previous studies (Huff et al., 2004; Lau et al., 2010; Oliveira et al., 2010; Kaikabo et al., 2017) in which phage therapy improved growth rates and decreased mortality of chickens with severe respiratory infections caused by APEC.
The BWs of birds in all E. coli-challenged groups in this study were lower than unchallenged groups (Table 2) . Kaikabo et al. (2017) and Ask et al. (2006) reported similar results; E. coli challenge of chickens resulted in anorexia and reduced growth rates. In our study, the impact of E. coli challenge on growth was reduced by phage treatment, with a more pronounced effect with the poly-phage treatment versus single phage treatment. In addition, poly-phage treated birds regained weight at faster rates than birds treated with a single phage where birds treated with the poly-phage regained BW on day 14 post-challenge and birds treated with a single phage regained BW on day 21 post-challenge.
Contrary to expectations, poly-phage treatment increased performance in unchallenged birds as well, where BW in poly-phage treated birds was significantly higher than that in untreated birds or birds treated with only a single phage (Table 2 ). This is in contrast to earlier findings by similar studies on chickens where phagemediated growth improvements were not observed in broiler chickens after intramuscular injection of bacteriophages (Huff et al., 2004 (Huff et al., , 2010 Oliveira et al., 2009) . The reason for the positive effect in the current study is not clear, but growth rates are often impacted by subclinical infections and phage treatment may have helped reduce the effects of infections that were not readily apparent. However, the experiment was carried out in a biosecure facility. Similarly, poly-phage treatment is likely to have reduced the overall bacterial load in the lungs. Entrance or discharge of the phages into the gastrointestinal tract and their effects on the gut microbiota would be probably a possible reason for the increased BW in this group. These results seem to be consistent with other research, which found the beneficial influence of dietary supplementation of bacteriophage on the performance of pigs and laying hens (Yan et al., 2012; Kim et al., 2015) . More detailed studies are needed before a definitive conclusion can be made on this issue.
In the case of bacterial invasion of internal organs, the host-defense system often triggers a series of potent inflammatory events at the site of infection as a consequence of the recognition of the pathogens (Wang et al., 2015) . These events may lead to swelling/edema and the accumulation of plasma proteins in the infected organs (Wang et al., 2015) . Therefore, the significantly higher relative liver weights of E. coli-challenged birds treated with single phage (TM3) on days 3, 5, and 10 post-challenge compared to those treated with phage cocktail are likely to reflect inflammation and may be indicative of the severity of the infection in those birds (Table 3) . Moreover, the frequency of pericarditis and perihepatitis, which indicate systemic bacterial infection , was also lower in phage cocktail treated, E. coli-challenged birds compared with those treated with phage TM3 or with untreated birds (Table 5 ). In line with our result, it has been established that phage cocktails are more effective than a single phage in the treatment of Clostridium difficile (Nale et al., 2016) , Pseudomonas aeruginosa (Hall et al., 2012) , and Campylobacter jejuni (Wagenaar et al., 2005) infections. It has been already shown that bacteria can become resistant to phages by modifying particular cell surface receptors (Fischer et al., 2013; Tsonos et al., 2014b) . In addition, it has been suggested that the application of a combination of phages could decrease the likelihood of simultaneous development of bacterial resistance to genetically diverse phages and, therefore, diminish the impact of phage resistance (Chan et al., 2013) . In this study, the susceptibility of all re-isolated colonies was tested to answer the question as to whether differences in the outcomes of phage therapy were related to the development of phage resistance. However, we did not observe decreased susceptibility to either of the phage treatments in recovered bacterial isolates (data not shown). The presence of neutralizing antibodies may directly affect the outcome of phage therapy by binding to the bacteriophage and preventing antibacterial activity of the phage (Fischer et al., 2013; Aghebati-Maleki et al., 2016) . In the first part of the current study, phage TM3 was shown to have the longest viability in the bloodstream (circulation time up to 24 h). This is consistent with previous reports indicating that the capacity of phage to overcome serum neutralization can vary from one phage to another (Ly-Chatain, 2014; Kim et al., 2015) . Hence, we hypothesized that the lower efficacy of TM3 as compared to the phage cocktail is not related to its inactivation by the host immune system. Therefore, we suggest that the improved therapeutic efficacy of the phage cocktail can be partially explained by a synergistic effect as formerly described in the in vitro studies by Cornelissen et al. (2011 ), Schmerer et al. (2014 , and Bull et al. (2010) . The mechanism of synergism between phages may be linked to improved phage penetration due to the production of various polysaccharide depolymerize enzymes, which can damage the bacterial capsule and facilitate the access (Latka et al., 2017) . Hence, a combination of phages may collectively kill the bacterial population more effectively and may even improve the growth properties of other phages (Schmerer et al., 2014) .
In conclusion, to the best of our knowledge, this is the first study demonstrating an in vivo synergistic effect of a combination of bacteriophages in the control of colibacillosis induced by APEC in Japanese quails, In our study, methods were established to determine phage serum neutralization, which is of importance for screening phage candidates prior to phage therapy. Synergy between phages is a somewhat unexplored field and may prove to be a more consumer-friendly approach compared to genetic engineering of single phages in order to increase host broadness and therapy efficiency. However, a single animal trial was performed in the present study and more detailed studies on this topic are needed to understand synergy mechanisms not only in disease control but also in potential improvements of performance in healthy animals.
SUPPLEMENTARY DATA
Supplementary data are available at Poultry Science online. Figure S1 . Pictures of the 4 phages plaque sizes using the soft agar overlay method. (A); TM1, (B); TM2, (C); TM3; and (D); TM3. All 4 phage strains have flexible non-contractile tails belonging to the family of Siphoviridae in the order of Caudovirales (Ackermann, 2003) . Supplementary Table S1 . Estimated dimensions and genome sizes of 4 bacteriophages isolated from poultry sewages or feces.
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